Back to search

Article

TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection

2022-12-09

Abstract excerpt

The COVID-19 pandemic remains a global health threat and novel antiviral strategies are urgently needed. SARS-CoV-2 employs the cellular serine protease TMPRSS2 for entry into lung cells and TMPRSS2 inhibitors are being developed for COVID-19 therapy. However, the SARS-CoV-2 Omicron variant, which currently dominates the pandemic, prefers the endo/lysosomal cysteine protease cathepsin L over TMPRSS2 for cell entry...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
56350f58-89bf-52c1-a1c1-cca57cfd97a4
DOI
10.1101/2022.12.09.519765
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infectionDOI 10.1101/2022.12.09.519765
Select a neighboring publication to make it the new centre.